From: Salud Mesoamérica 2015 Initiative: design, implementation, and baseline findings
Country | # of facilities that reported routinely storing vaccines | Availability on day of survey* (%) | # of facilities evaluated for previous months’ stock** | Stock-outs in facilities with all vaccines available on day of survey** (%) | |||||
---|---|---|---|---|---|---|---|---|---|
BCG | MMR | Pentavalent | Pneumonia | Rotavirus | BCG | MMR | |||
Belize | 10 | 100 | 100 | 100 | *** | *** | 9 | 0.0 | 0.0 |
El Salvador | 28 | 78.6 | 76.9 | 96.4 | 71.4 | 75.0 | *** | **** | **** |
Guatemala | 55 | 96.4 | 96.4 | 96.4 | 92.7 | 90.9 | 33 | 3.0 | 3.0 |
Honduras | 84 | 86.9 | 77.4 | 78.6 | 76.2 | 75.0 | 9 | 22.2 | 11.1 |
Mexico | 37 | 73.0 | 83.8 | 78.4 | 40.5 | 78.4 | 7 | 42.9 | 57.1 |
Nicaragua | 41 | 31.7 | 95.1 | 97.6 | 65.9 | 92.7 | 1 | 0.0 | 0.0 |
Panama | 14 | 100 | 92.9 | 100 | 100 | 100 | 11 | 9.1 | 9.1 |